Modernising Medical Microbiology
Modernising Medical Microbiology is a research group aiming to transform how we analyse and treat infections, to improve patient care.
You can read more about our background, objectives and future plans from Professor Derrick Crook, in an article with IMPACT Journal here.
We aim to:
1) Modernise the way we analyse infections, bringing cutting-edge scientific techniques to clinical care.
2) Transform they way we study the treatment of patients with infections, using large databases of hospital electronic information, to identify trends in how infections are behaving, and ways patient care can be improved.
3) Use techniques such as DNA analysis of bacteria and viruses to better understand how infections spread, how to treat them, and how to prevent them in the future.
4) Study how bacteria become resistant to antibiotics, and more difficult to treat, and how to prevent this.
and how to prevent this.
Modernising Medical Microbiology studies a number of infections, in particular, Mycobacterium tuberculosis (TB), - the Enterobacterales family (Escherichia coli, Klebsiella species and others) and Clostridium difficile (C. diff).
You can learn more about these bacteria here
The Modernising Medical Microbiology Research Group has many active research projects.
You can learn more about the projects here.
If you are interested in being a part of our public engagement team, please get in contact!
Pathogens and viruses
What Pathogens and Viruses do the MMM team research?
High-resolution characterization of short-term temporal variability in the taxonomic and resistome composition of wastewater influent.
Chau KK. et al, (2023), Microbial genomics, 9
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Wei J. et al, (2023), Nature communications, 14
Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study
Bosworth ML. et al, (2023)
Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile
Dingle KE. et al, (2023), mBio
COVID-19: accelerating testing with robotics
Kevin Chau, a PhD student on our National PhD Training Programme in AMR Research, has contributed to the pandemic response as part of the Modernising Medical Microbiology team at John Radcliffe Hospital in Oxford. In a new blog post, he describes the experience.
Monitoring Populations at risk from Coronavirus
Emma Pritchard, Statistician and PhD student shares her work with ONS on Coronavirus statistics.